RFK Jr. ends Emergency Use Authorizations for COVID-19 drugs

[Medication of antiviral capsule(medicine drug) for treatment and prevention of new corona virus infection(COVID-19,novel coronavirus disease 2019 or nCoV 2019 from Wuhan. Pandemic infectious concept]
sittithat tangwitthayaphum

* HHS Secretary Robert F. Kennedy Jr. has terminated Emergency Use Authorizations for drugs and medical devices to treat COVID-19.
* The EUAs for drugs and biologics will end [https://www.hhs.gov/press-room/hhs-ends-covid-19-emergency-use-authorizations.html] in 12 months and in 180 days for medical devices.
* COVID vaccines are not impacted by today's action given that the three shots available in the US, manufactured by Moderna (MRNA [https://seekingalpha.com/symbol/MRNA]), Pfizer (PFE [https://seekingalpha.com/symbol/PFE])/BioNTech (BNTX [https://seekingalpha.com/symbol/BNTX]), and Novavax (NVAX [https://seekingalpha.com/symbol/NVAX]) have received traditional approval following their own EUAs.
* Drugs such as Pfizer's Paxlovid (nirmatrelvir/ritonavir) and Merck's (MRK [https://seekingalpha.com/symbol/MRK]) Lagrevio (molnupiravir) are impacted by the directive.

MORE ON PFIZER, MERCK

* Pfizer: Why Being Bullish Makes Sense Despite The Patent Cliff [https://seekingalpha.com/article/4918091-pfizer-why-being-bullish-makes-sense-despite-the-patent-cliff]
* Antibody-Drug Conjugates: Not Quite Worked Out Yet [https://seekingalpha.com/article/4917846-antibody-drug-conjugates-not-quite-worked-out-yet]
* Merck's Oncology Engine Is Still Accelerating [https://seekingalpha.com/article/4916712-merck-oncology-engine-still-accelerating]
* FDA commissioner contenders down to three - report [https://seekingalpha.com/news/4607782-fda-commissioner-contenders-down-three]
* Record-setting healthcare M&A activity to extend through H2: PwC [https://seekingalpha.com/news/4607460-record-setting-healthcare-ma-extend-through-h2]